Oncology: targets and experimental approaches

Different peptide functions

In oncology, a peptide may be studied as a target-binding ligand, an inhibitor of a molecular interaction or part of a construct carrying another entity. These functions differ: recognizing a cell does not by itself demonstrate killing it.

Selectivity before generalization

Ask which target was measured, how expression was confirmed and whether target-negative or non-tumor controls were used. Reduced viability can reflect different mechanisms; the assay and controls should support consideration of those alternatives.

Models and endpoints

Separate binding, internalization, viability and tumor-growth results. Record whether the model is a culture, organoid or organism without assuming equivalence. Formulation, distribution and exposure become essential as research moves beyond cells.

What to check in the source

Locate the molecular construct in the review and follow the reference for the specific experiment. Do not transfer results from a conjugate to the free peptide or from one tumor model to all cancers. This is a scientific guide, not a use indication for catalog materials.

Related reading